Aug 182016
Talent4Boards - Great Talent builds Great Boards
– USA, FL – Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced it has appointed Anne M.… => Read more
Applied Genetic Technologies (AGCT) appoints Anne VanLent to the Board of Directors
From:: Applied Genetic Technologies (AGCT) appoints Anne VanLent to the Board of Directors
Sorry, the comment form is closed at this time.